Author:
Calvo Felipe A.,Aristu Javier,Serrano Javier,Cambeiro Mauricio,Martinez-Monge Rafael,Cañón Rosa
Publisher
Springer Berlin Heidelberg
Reference57 articles.
1. Abe M, Takahashi M (1981) Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 7(7):863–868
2. Antonia SJ, Villegas A, Daniel DN et al (2017) Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 377:1919–1929
3. Arian-Schad Juellner FM, Ratzenhofer B et al (1990) Intraoperative plus external beam irradiation in nonresectable lung cancer: assessment of local response and therapy-relate side effects. Radiother Oncol 119:137–144
4. Aristu J, Rebollo J, Martínez-Monge R, Aramendía JM et al (1997) Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small-cell lung cancer: final results of a phase II study. Am J Clin Oncol 20:276–281
5. Aristu JJ, Calvo FA, Martínez R, Dubois JB, Santos M, Fisher S, Azinovic I (1999) Lung cancer: EBRT with or without IORT. In: Gunderson LL, Willet CG, Harrison LB, Calvo FA (eds) Intraoperative irradiation. Techniques and results. Humana, Totowa, pp 437–453